Bu-Hui Liu

473 total citations
21 papers, 378 citations indexed

About

Bu-Hui Liu is a scholar working on Molecular Biology, Nephrology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Bu-Hui Liu has authored 21 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Nephrology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Bu-Hui Liu's work include Inflammasome and immune disorders (5 papers), Renal Diseases and Glomerulopathies (4 papers) and Lipid metabolism and disorders (3 papers). Bu-Hui Liu is often cited by papers focused on Inflammasome and immune disorders (5 papers), Renal Diseases and Glomerulopathies (4 papers) and Lipid metabolism and disorders (3 papers). Bu-Hui Liu collaborates with scholars based in China, Japan and Malaysia. Bu-Hui Liu's co-authors include Yi‐Gang Wan, Yue Tu, Zi-Yue Wan, Qi‐Jun Fang, Yinglu Liu, Wei Wu, Wei Sun, Meizi Wang, Weiming He and Renmao Tang and has published in prestigious journals such as Frontiers in Microbiology, Frontiers in Pharmacology and Aging.

In The Last Decade

Bu-Hui Liu

21 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bu-Hui Liu China 9 198 108 50 41 40 21 378
Yilan Shen China 10 212 1.1× 99 0.9× 60 1.2× 42 1.0× 51 1.3× 20 453
Zi-Yue Wan China 10 248 1.3× 153 1.4× 56 1.1× 42 1.0× 47 1.2× 17 457
Xia Zhong China 10 150 0.8× 89 0.8× 42 0.8× 38 0.9× 47 1.2× 24 359
Yanru Huang China 12 183 0.9× 79 0.7× 42 0.8× 36 0.9× 45 1.1× 29 434
Enchao Zhou China 12 204 1.0× 105 1.0× 40 0.8× 46 1.1× 41 1.0× 25 487
Montserrat B. Duran-Salgado Mexico 4 107 0.5× 109 1.0× 47 0.9× 42 1.0× 44 1.1× 6 349
Shuang Chu China 10 148 0.7× 83 0.8× 83 1.7× 94 2.3× 52 1.3× 12 434
Anni Song China 9 142 0.7× 119 1.1× 58 1.2× 44 1.1× 26 0.7× 16 424
Anmei Shu China 9 211 1.1× 67 0.6× 35 0.7× 28 0.7× 44 1.1× 13 402

Countries citing papers authored by Bu-Hui Liu

Since Specialization
Citations

This map shows the geographic impact of Bu-Hui Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bu-Hui Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bu-Hui Liu more than expected).

Fields of papers citing papers by Bu-Hui Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bu-Hui Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bu-Hui Liu. The network helps show where Bu-Hui Liu may publish in the future.

Co-authorship network of co-authors of Bu-Hui Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Bu-Hui Liu. A scholar is included among the top collaborators of Bu-Hui Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bu-Hui Liu. Bu-Hui Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Yining, Chao Han, Xiaofan Yin, et al.. (2024). Role of N-acetylkynurenine in mediating the effect of gut microbiota on urinary tract infection: a Mendelian randomization study. Frontiers in Microbiology. 15. 1384095–1384095. 1 indexed citations
2.
Wang, Meizi, Jie Wang, Dongwei Cao, et al.. (2022). Fucoidan Alleviates Renal Fibrosis in Diabetic Kidney Disease via Inhibition of NLRP3 Inflammasome-Mediated Podocyte Pyroptosis. Frontiers in Pharmacology. 13. 790937–790937. 47 indexed citations
3.
Wang, Wenwen, Yinglu Liu, Meizi Wang, et al.. (2021). Inhibition of Renal Tubular Epithelial Mesenchymal Transition and Endoplasmic Reticulum Stress-Induced Apoptosis with Shenkang Injection Attenuates Diabetic Tubulopathy. Frontiers in Pharmacology. 12. 662706–662706. 28 indexed citations
4.
Liu, Bu-Hui, Yinglu Liu, Haiming Yang, et al.. (2021). Fucoidan Ameliorates Renal Injury-Related Calcium-Phosphorus Metabolic Disorder and Bone Abnormality in the CKD–MBD Model Rats by Targeting FGF23-Klotho Signaling Axis. Frontiers in Pharmacology. 11. 586725–586725. 14 indexed citations
5.
Wang, Meizi, Lijun Yue, Yi‐Gang Wan, et al.. (2021). [Effects and mechanisms of Supplemented Gegen Qinlian Decoction Formula against podocyte pyroptosis and insulin resistance in model rats with diabetic kidney disease].. China Journal of Chinese Materia Medica. 46(17). 4471–4479. 2 indexed citations
6.
7.
8.
Wang, Wenwen, Yi‐Gang Wan, Yue Tu, et al.. (2020). [Molecular regulative mechanisms of NLRP3 inflammasome activation in diabetic nephropathy and interventional effects of Chinese herbal medicine].. PubMed. 45(1). 7–13. 3 indexed citations
9.
Wu, Wei, Yinglu Liu, Yi‐Gang Wan, et al.. (2020). [Multi-targeted therapeutic effects of Huangkui Capsules on insulin resistance and urine microalbumin in early diabetic kidney disease patients].. PubMed. 45(23). 5797–5803. 4 indexed citations
10.
Fang, Qi‐Jun, Jianjing Liu, Yi‐Gang Wan, et al.. (2020). [Exploring molecular mechanisms of fucoidan in improving human proximal renal tubular epithelial cells aging by targeting autophagy signaling pathways].. PubMed. 45(24). 6003–6011. 4 indexed citations
11.
Liu, Bu-Hui, Meizi Wang, Wei Sun, et al.. (2020). [Molecular regulatory mechanisms of hypoxia-inducible factor and interventional effect of Chinese herbal medicine].. PubMed. 45(20). 4805–4811. 2 indexed citations
12.
Li, Wei, Weiming He, Ping Xia, et al.. (2019). Total Extracts of Abelmoschus manihot L. Attenuates Adriamycin-Induced Renal Tubule Injury via Suppression of ROS-ERK1/2-Mediated NLRP3 Inflammasome Activation. Frontiers in Pharmacology. 10. 567–567. 46 indexed citations
13.
Liu, Yinglu, Ge Shi, Wenwen Wang, et al.. (2019). Shenkang injection, a modern preparation of Chinese patent medicine, diminishes tubulointerstitial fibrosis in obstructive nephropathy via targeting pericyte-myofibroblast transition.. PubMed. 11(4). 1980–1996. 17 indexed citations
14.
Wu, Wei, Bu-Hui Liu, Yi‐Gang Wan, et al.. (2019). [Triptolide inhibits NLRP3 inflammasome activation and ameliorates podocyte epithelial-mesenchymal transition induced by high glucose].. PubMed. 44(24). 5457–5464. 10 indexed citations
15.
Tu, Yue, Yi‐Gang Wan, Bu-Hui Liu, et al.. (2019). [Molecular mechanisms of non-coding RNA regulating autophagy and interventional effects of Chinese herbal medicine].. PubMed. 44(21). 4545–4551. 2 indexed citations
16.
17.
Liu, Yinglu, Ge Shi, Dongwei Cao, et al.. (2018). [Pathomechanisms of pericyte-myofibroblast transition in kidney and interventional effects of Chinese herbal medicine].. PubMed. 43(21). 4192–4197. 2 indexed citations
18.
19.
Liu, Bu-Hui, Yue Tu, Weiming He, et al.. (2018). Hyperoside attenuates renal aging and injury induced by D-galactose via inhibiting AMPK-ULK1 signaling-mediated autophagy. Aging. 10(12). 4197–4212. 61 indexed citations
20.
Wu, Wei, Jingjing Yang, Yi‐Gang Wan, et al.. (2017). [Pathogenesis and treatment of insulin resistance in chronic kidney disease and interventional effects of Chinese herbal medicine].. PubMed. 42(1). 49–55. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yilan Shen Breakdown of academic impact, for papers by Zi-Yue Wan Breakdown of academic impact, for papers by Xia Zhong Breakdown of academic impact, for papers by Yanru Huang Breakdown of academic impact, for papers by Enchao Zhou Breakdown of academic impact, for papers by Montserrat B. Duran-Salgado Breakdown of academic impact, for papers by Shuang Chu Breakdown of academic impact, for papers by Anni Song Breakdown of academic impact, for papers by Anmei Shu
Rankless by CCL
2026